Brivudine - Berlin Chemie

Drug Profile

Brivudine - Berlin Chemie

Alternative Names: Brivudin; Bromovinyldeoxyuridine; BVDU; Zostex

Latest Information Update: 06 Oct 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Berlin Chemie
  • Class Adjuvants; Antivirals; Deoxyribonucleosides; Pyrimidine nucleosides; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors; Thymidylate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Herpes zoster
  • Discontinued Cancer; Herpes simplex virus infections; Varicella zoster virus infections

Most Recent Events

  • 26 Apr 2001 Two phase III trials have been added to the Viral Infections therapeutic trials and adverse events sections
  • 26 Mar 2001 Phase-III clinical trials for Herpes zoster in Europe (PO)
  • 26 Mar 2001 Phase-III clinical trials for Herpes zoster in Israel (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top